APA

Melosky B., Bradbury P., Tu D., Florescu M., Reiman A., Nicholas G., Basappa N., Rothenstein J., Goffin J. R., Laurie S. A., Wheatley-Price P., Leighl N., Goss G., Reaume M. N., Butts C., Murray N., Card C., Ko J., Blais N., Gray S., Lui H., Brown-Walker P., Kaurah P., Prentice L. M. & Seymour L. (20200305). Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219. : Lung cancer (Amsterdam, Netherlands).

Chicago

Melosky Barbara, Bradbury Penelope, Tu Dongsheng, Florescu Marie, Reiman Anthony, Nicholas Garth, Basappa Naveen, Rothenstein Jeffrey, Goffin John R, Laurie Scott A, Wheatley-Price Paul, Leighl Natasha, Goss Glenwood, Reaume M Neil, Butts Charles, Murray Nevin, Card Cynthia, Ko Jenny, Blais Normand, Gray Samantha, Lui Hongbo, Brown-Walker Pamela, Kaurah Pardeep, Prentice Leah M and Seymour Lesley. 20200305. Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219. : Lung cancer (Amsterdam, Netherlands).

Harvard

Melosky B., Bradbury P., Tu D., Florescu M., Reiman A., Nicholas G., Basappa N., Rothenstein J., Goffin J. R., Laurie S. A., Wheatley-Price P., Leighl N., Goss G., Reaume M. N., Butts C., Murray N., Card C., Ko J., Blais N., Gray S., Lui H., Brown-Walker P., Kaurah P., Prentice L. M. and Seymour L. (20200305). Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219. : Lung cancer (Amsterdam, Netherlands).

MLA

Melosky Barbara, Bradbury Penelope, Tu Dongsheng, Florescu Marie, Reiman Anthony, Nicholas Garth, Basappa Naveen, Rothenstein Jeffrey, Goffin John R, Laurie Scott A, Wheatley-Price Paul, Leighl Natasha, Goss Glenwood, Reaume M Neil, Butts Charles, Murray Nevin, Card Cynthia, Ko Jenny, Blais Normand, Gray Samantha, Lui Hongbo, Brown-Walker Pamela, Kaurah Pardeep, Prentice Leah M and Seymour Lesley. Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219. : Lung cancer (Amsterdam, Netherlands). 20200305.